Mainstream

Xenon targets NDA filing for azetukalner within 6 months of phase III readout while advancing late-stage neuropsychiatric programs

Xenon targets NDA filing for azetukalner within 6 months of phase III readout while advancing late-stage neuropsychiatric programs

Post ContentxeneRead More

You might also be interested in reading Bitcoin price trades sideways as old wallets sell into institutional demand.

August 12, 2025
In Mainstream